Abstract
BackgroundMajor Depressive Disorder (MDD) is the leading psychiatric disorder in low- and middle-income countries, and is to be the second leading cause of burden of disease by 2020. Cortisol plays a significant role in pathophysiology of MDD. Depression can alter serum cortisol level. However, the change in serum cortisol level and its association with depressive symptom severity and improvement among patients with MDD is not well studied.ObjectiveTo outline change in serum cortisol levels and its association with severity and improvement of depressive symptoms in newly diagnosed patients with MDD.MethodHospital based longitudinal study was conducted among 34 newly diagnosed patients who met DSM-V criteria of MDD. Venous blood sample was performed twice; pre- and post- 8 weeks of treatment. Serum cortisol concentration was measured using an extracted radioimmunoassay. The 17-item Hamilton Depression Scale (HAM-D) was used to rate depression at baseline and after 8 weeks of treatment. Paired t-test was done to look the mean difference of serum cortisol level and HAM-D, before and after treatment. Pearson correlation was done to look the association between serum cortisol levels, HAM-D scores and, sociodemographic and clinical factors. Statistical significance was set at p<0.05.ResultsThere is no significant difference in cortisol concentrations at baseline and end line (t (33) = 2.02, p = 0.052). However, there is significant difference in HAM-D total score (t (33) = 5.67, p<0.001). Baseline and end line serum cortisol levels were significantly correlated (r = .561, p = .001). Monthly family income is correlated with baseline HAM-D total score (r = -0.373, p = .030). There is no significant relationship between baseline serum cortisol level and HAM-D score. There is also no significant relationship between end line serum cortisol level and HAM-D score.ConclusionsThe symptoms of MDD were reduced following treatment but there is no significant difference in serum cortisol levels. Baseline and end line serum cortisol levels were significantly correlated. We recommend further research based on large sample.
Highlights
The symptoms of Major Depressive Disorder (MDD) were reduced following treatment but there is no significant difference in serum cortisol levels
Major Depressive Disorder (MDD) is characterized by persistent low mood and/or loss of interest in pleasurable activities which result in an inability to carry out daily activities [1]
It is well described that the functional changes of the hypothalamus pituitary adrenal (HPA) axis occur in patients with MDD and associated variation of serum cortisol level [5]
Summary
Major Depressive Disorder (MDD) is characterized by persistent low mood and/or loss of interest in pleasurable activities which result in an inability to carry out daily activities [1]. A major focus in studies of the relationship between stress and depression is the role of the HPA axis, both as a marker of stress responses and as a mediator of additional pathological consequences [4,5]. It is well described that the functional changes of the HPA axis occur in patients with MDD and associated variation of serum cortisol level [5]. Presence of severe depressive symptoms is due to the high level of serum cortisol and recommended as a biomarker of MDD [6]. Major Depressive Disorder (MDD) is the leading psychiatric disorder in low- and middleincome countries, and is to be the second leading cause of burden of disease by 2020. The change in serum cortisol level and its association with depressive symptom severity and improvement among patients with MDD is not well studied
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have